BACKGROUND: Sublingual misoprostol has been shown to be effective in medical abortion.
A prospective double-blinded placebo-controlled trial was done to compare the efficacy and …

Pregnancy was terminated by repeated doses of vaginal misoprostol in 20 women at a
gestational age of less than 9 weeks. The women were given 800 μg of vaginal misoprostol …

Objective: The purpose of this study was to compare the abortifacient effect of intravaginally
administered moistened misoprostol tablets with that of the combination regimen of …

Misoprostol is being used widely by women throughout Latin America, often based on
instructions passed along through friends, acquaintances or professionals who may have …

BACKGROUND: Buccal misoprostol 800 mcg and sublingual misoprostol 400 mcg
demonstrate high efficacy and few adverse effects when used with 200 mg mifepristone for …

Objectives: The aim of the study was to assess the efficacy and acceptability of a regimen
using mifepristone and buccal misoprostol with unlimited dosing for second trimester …

The aim of this study was to investigate the efficacy, safety, and acceptability of low-dose
mifepristone combined with self-administered misoprostol for ultra-early medical abortion. A …

In September 2000, the Food and Drug Administration (FDA) approved mifepristone (also
known by the trade name Mifeprex or its original French name, RU-486) for use along with a …

Objective To assess differences in outcomes of misoprostol with or without mifepristone for
second-trimester abortion. Methods A randomized, double-blind, placebo-controlled trial of …

OBJECTIVE: To review published reports of first-trimester medical abortion regimens that do
not include mifepristone. METHODS: Reports listed in Pubmed and Medline on prospective …